Analysis of coagulation during ECMO

Analysis of coagulation during ECMO - ECMO-Coagulation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005650

Enrollment

Registered

2014-05-23

Start date

2014-05-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J80

Interventions

Group 1: Observational study, detailed analysis of coagulation function during during the course of ECMO

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Newly installed ECMO

Exclusion criteria

Exclusion criteria: ARDS not indicated for ECMO therapy, ECMO for other indications than ARDS

Design outcomes

Primary

Measure	Time frame
During ECMO the course of coagulation function will be monitored Anlysis includes general amrkers (Quick, aPTT, Fibrinogen, Thrombozyt count, AT-III, Xa-Activity, D-Dimers, ACT) and activity of coagulation factors (II, V, VII, VIII, IX, X, XII, XIII, vWF-antigen and activity)	—

Countries

Germany

Contacts

Public ContactOnnen Mörer

Universitätsmedizin Göttingen

omoerer@gwdg.de0551399561

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026